IP Library Granted Patent US 7,361,483
Granted Patent B2
US 7,361,483 · App. 11/342,328 · Granted Apr 22, 2008

Aromatic prenyltransferases, nucleic acids encoding same and uses therefor

Assignees: The Salk Institute for Biological Studies; Toudai TLO, Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,361,483
App. No.
11/342,328
Granted
Apr 22, 2008
Kind
B2
Abstract

In accordance with the present invention, a novel aromatic prenyltransferase, Orf2 from Streptomyces sp. strain CL190, involved in naphterpin biosynthesis has been identified and the structure thereof elucidated. This prenyltransferase catalyzes the formation of a C—C bond between a prenyl group and a compound containing an aromatic nucleus, and also displays C—O bond formation activity. Numerous crystallographic structures of the prenyltransferase have been solved and refined, e.g., (1) prenyltransferase complexed with a buffer molecule (TAPS), (2) prenyltransferase as a binary complex with geranyl diphosphate (GPP) and Mg 2+ , and prenyltransferase as ternary complexes with a non-hydrolyzable substrate analogue, geranyl S-thiolodiphosphate (GSPP) and either (3) 1,6-dihydroxynaphthalene (1,6-DHN), or (4) flaviolin (i.e., 2,5,7-trihydroxy-1,4-naphthoquinone, which is the oxidized product of 1,3,6,8-tetrahydroxynaphthalene (THN)). These structures have been solved and refined to 1.5 Å, 2.25 Å, 1.95 Å and 2.02 Å, respectively. This first structure of an aromatic prenyltransferase displays an unexpected and non-canonical (β/α)-barrel architecture. The complexes with both aromatic substrates and prenyl containing substrates and analogs delineate the active site and are consistent with a proposed electrophilic mechanism of prenyl group transfer. These structures also provide a mechanistic basis for understanding prenyl chain length determination and aromatic co-substrate recognition in this structurally unique family of aromatic prenyltransferases. This structural information is useful for predicting the aromatic prenyltransferase activity of proteins.

Claims (9)

1. An isolated and purified non-crystalline aromatic prenyltransferase having a beta/alpha barrel structure and at least 95% sequence identity with the amino acid sequence set forth in SEQ ID NO:2.

2. An aromatic prenyltransferase according to claim 1 , wherein said aromatic prenyltransferase has the amino acid sequence set forth in SEQ ID NO:2.

3. A method of identifying a potential inhibitor of the activity of an aromatic prenyltransferase according to claim 1 , said method comprising:

contacting said aromatic prenyltransferase with a potential compound; and

determining the ability of said compound to inhibit the activity of said aromatic prenyltransferase, whereby those compounds which inhibit the activity of said aromatic prenyltransferase are identified as inhibitors of the activity of said aromatic prenyltransferase.

4. A composition comprising an aromatic prenyltransferase consisting of the amino acid seguence of SEQ ID NO:2 in crystalline form, wherein the crystalline form of said aromatic prenyltransferase has space group P2 1 2 1 2, with average unit cell dimensions of a=71 Å, b=92 Å, c=48 Å, α=β=γ=90°.

5. A composition according to claim 4 , wherein the crystalline form of said aromatic prenyltransferase contains one monomer per asymmetric unit and a solvent content of 45%.

6. A composition according to claim 4 , wherein said prenyltransferase having the structural coordinates set forth in Appendix 1.

7. A composition according to claim 5 having the structural coordinates set forth in Appendix 1.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2019
From: TOUDAI TLO, LTD., NOW KNOWN AS TODAI TLO, LTD.
To: THE SALK INSTITUTE FOR BIOLOGICAL STUDIES
Reel/Frame 048239/0374 →
CONFIRMATORY LICENSE Recorded Jan 29, 2014
From: SALK INSTITUTE FOR BIOLOGICAL STUDIES
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 032140/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2006
From: KUZUYAMA, TOMOHISA
To: TOUDAI TLO, LTD.
Reel/Frame 017503/0634 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2006
From: NOEL, JOSEPH P.; RICHARD, STEPHANE P.
To: THE SALK INSTITUTE FOR BIOLOGICAL STUDIES
Reel/Frame 017503/0670 →
Continuity (2)
Provisional Application 6064804600 · Jan 28, 2005
Related Publication 20060183211A1 · Aug 17, 2006